Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab

Detalles Bibliográficos
Autores principales: Ellithi, Moataz, Shahid, Mahum, Abdullah, Hafez Mohammad, Bleeker, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446228/
https://www.ncbi.nlm.nih.gov/pubmed/32265146
http://dx.doi.org/10.1016/j.htct.2020.02.001
_version_ 1784568828361965568
author Ellithi, Moataz
Shahid, Mahum
Abdullah, Hafez Mohammad
Bleeker, Jonathan
author_facet Ellithi, Moataz
Shahid, Mahum
Abdullah, Hafez Mohammad
Bleeker, Jonathan
author_sort Ellithi, Moataz
collection PubMed
description
format Online
Article
Text
id pubmed-8446228
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-84462282021-09-24 Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab Ellithi, Moataz Shahid, Mahum Abdullah, Hafez Mohammad Bleeker, Jonathan Hematol Transfus Cell Ther Case Report Sociedade Brasileira de Hematologia e Hemoterapia 2021 2020-03-25 /pmc/articles/PMC8446228/ /pubmed/32265146 http://dx.doi.org/10.1016/j.htct.2020.02.001 Text en © 2020 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ellithi, Moataz
Shahid, Mahum
Abdullah, Hafez Mohammad
Bleeker, Jonathan
Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_full Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_fullStr Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_full_unstemmed Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_short Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
title_sort complement c3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446228/
https://www.ncbi.nlm.nih.gov/pubmed/32265146
http://dx.doi.org/10.1016/j.htct.2020.02.001
work_keys_str_mv AT ellithimoataz complementc3mutationcausingatypicalhemolyticuremicsyndromesuccessfullytreatedwitheculizumab
AT shahidmahum complementc3mutationcausingatypicalhemolyticuremicsyndromesuccessfullytreatedwitheculizumab
AT abdullahhafezmohammad complementc3mutationcausingatypicalhemolyticuremicsyndromesuccessfullytreatedwitheculizumab
AT bleekerjonathan complementc3mutationcausingatypicalhemolyticuremicsyndromesuccessfullytreatedwitheculizumab

Ejemplares similares